Marieke Begemann

3.2k total citations
50 papers, 2.0k citations indexed

About

Marieke Begemann is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, Marieke Begemann has authored 50 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Psychiatry and Mental health, 11 papers in Cognitive Neuroscience and 10 papers in Clinical Psychology. Recurrent topics in Marieke Begemann's work include Schizophrenia research and treatment (30 papers), Psychosomatic Disorders and Their Treatments (7 papers) and Tryptophan and brain disorders (6 papers). Marieke Begemann is often cited by papers focused on Schizophrenia research and treatment (30 papers), Psychosomatic Disorders and Their Treatments (7 papers) and Tryptophan and brain disorders (6 papers). Marieke Begemann collaborates with scholars based in Netherlands, United Kingdom and Norway. Marieke Begemann's co-authors include Iris E. Sommer, Sophie M. Heringa, Stefan Leucht, Meenakshi Dauwan, René S. Kahn, André Alemán, Lot D. de Witte, Bodyl A. Brand, Branislava Ćurĉić‐Blake and Roos van Westrhenen and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Psychiatry and Brain.

In The Last Decade

Marieke Begemann

45 papers receiving 2.0k citations

Peers

Countries citing papers authored by Marieke Begemann

Since Specialization

Citations

This map shows the geographic impact of Marieke Begemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marieke Begemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marieke Begemann more than expected).

Fields of papers citing papers by Marieke Begemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marieke Begemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marieke Begemann. The network helps show where Marieke Begemann may publish in the future.

Co-authorship network of co-authors of Marieke Begemann

This figure shows the co-authorship network connecting the top 25 collaborators of Marieke Begemann. A scholar is included among the top collaborators of Marieke Begemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marieke Begemann. Marieke Begemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cumulative exposure to childhood adversity and risk of adult psychosis: a dose–response meta-analysis 2025 ·Psychological Medicine ·(unknown), (unknown), Sophie Parker, Kate Allsopp, Lan Zhou, Marieke Begemann, Richard P. Bentall, Filippo Varese	0
2	Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission 2025 ·JAMA Psychiatry ·Iris E. Sommer, (unknown), Shiral S. Gangadin, Lieuwe de Haan, Wim Veling, Nico van Beveren, Nynke Boonstra, (unknown), Jim van Os, Martijn Kikkert, Sanne Koops, (unknown), Frederick W. Thielen, Ben Wijnen, Marieke Begemann	0
3	Antipsychotic dopamine D2 affinity and negative symptoms in remitted first episode psychosis patients 2024 ·Schizophrenia Research ·(unknown), Ben Wijnen, (unknown), Sanne Koops, Shiral S. Gangadin, Wim Veling, Nico van Beveren, Lieuwe de Haan, Marieke Begemann, Iris E. Sommer	0
4	Associations between momentary mental states and concurrent social functioning after remission from first episode psychosis: A HAMLETT ecological momentary assessment study 2024 ·Journal of Psychiatric Research ·(unknown), Hannah E. Jongsma, Claudia J.P. Simons, (unknown), Lieuwe de Haan, Nynke Boonstra, Martijn Kikkert, Sanne Koops, Chris Geraets, Marieke Begemann, Machteld Marcelis, Wim Veling	1
5	Psychiatrists effect on positive symptom severity and daily functioning during pharmacotherapy for first-episode psychosis patients 2024 ·Scientific Reports ·(unknown), Sanne Koops, Robert A. Schoevers, Wim Veling, Nico van Beveren, Lieuwe de Haan, Nynke Boonstra, Martijn Kikkert, Marieke Begemann, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
6	Personal recovery in first-episode psychosis: Beyond clinical and functional recovery 2024 ·Schizophrenia Research ·(unknown), Marc M. Bohlken, Shiral S. Gangadin, (unknown), Wim Veling, Nynke Boonstra, Lieuwe de Haan, Marieke Begemann, Sanne Koops	1
7	Social Deafferentation and the Relation Between Loneliness and Hallucinations 2023 ·Schizophrenia Bulletin ·Sanne Brederoo, Janna N. de Boer, Mascha M.J. Linszen, Renske E. Blom, Marieke Begemann, Iris E. Sommer	6
8	Occurrence and phenomenology of hallucinations in the general population: A large online survey 2022 ·SHILAP Revista de lepidopterología ·Mascha M.J. Linszen, Janna N. de Boer, Maya Schutte, Marieke Begemann, (unknown), Sanne Koops, Renske E. Blom, Marc M. Bohlken, Sophie M. Heringa, Jan Dirk Blom, Iris E. Sommer	32
9	Lower fractional anisotropy without evidence for neuro-inflammation in patients with early-phase schizophrenia spectrum disorders 2022 ·Schizophrenia Research ·Shiral S. Gangadin, René C.W. Mandl, Lot D. de Witte, Neeltje E.M. van Haren, Maya Schutte, Marieke Begemann, René S. Kahn, Iris E. Sommer	4
10	Language in schizophrenia: relation with diagnosis, symptomatology and white matter tracts 2020 ·Schizophrenia ·Janna N. de Boer, (unknown), René C.W. Mandl, (unknown), Alban Voppel, Marieke Begemann, Edwin van Dellen, Frank Wijnen, Iris E. Sommer	63
11	Drugs with anti-inflammatory effects to improve outcome of traumatic brain injury: a meta-analysis 2020 ·Scientific Reports ·Marieke Begemann, (unknown), Harm J. van der Horn, Joukje van der Naalt, Iris E. Sommer	26
12	No association between anti-thyroidperoxidase antibodies and bipolar disorder: a study in the Dutch Bipolar Cohort and a meta-analysis 2019 ·Psychoneuroendocrinology ·Gijsje J. L. Snijders, Lot D. de Witte, (unknown), (unknown), Eline J. Regeer, Marieke Begemann, Amber Berdenis van Berlekom, Manja Litjens, Marco P. Boks, Roel A. Ophoff, René S. Kahn, Manon H. J. Hillegers	5
13	Physical exercise improves quality of life, depressive symptoms, and cognition across chronic brain disorders: a transdiagnostic systematic review and meta-analysis of randomized controlled trials 2019 ·Journal of Neurology ·Meenakshi Dauwan, Marieke Begemann, (unknown), Edwin Lee, Philip Scheltens, Iris E. Sommer	157
14	Immediate and long-term effects of bilateral electroconvulsive therapy on cognitive functioning in patients with a depressive disorder 2018 ·Journal of Affective Disorders ·Jasper O. Nuninga, (unknown), Metten Somers, René C.W. Mandl, (unknown), Marco P. Boks, Steven C. Bakker, Marieke Begemann, Sophie M. Heringa, Iris E. Sommer	41
15	Childhood abuse and white matter integrity in bipolar disorder patients and healthy controls 2018 ·European Neuropsychopharmacology ·Remi Stevelink, Lucija Abramovic, Sanne Verkooijen, Marieke Begemann, Iris E. Sommer, Marco P. Boks, René C.W. Mandl, Neeltje E.M. van Haren, Christiaan H. Vinkers	16
16	Clinical use of semantic space models in psychiatry and neurology: A systematic review and meta-analysis 2018 ·Neuroscience & Biobehavioral Reviews ·Janna N. de Boer, Alban Voppel, Marieke Begemann, Hugo G. Schnack, Frank Wijnen, Iris E. Sommer	37
17	Simvastatin augmentation for recent-onset psychotic disorder: A study protocol 2015 ·SHILAP Revista de lepidopterología ·Marieke Begemann, Maya Schutte, (unknown), Janine Doorduin, P. Roberto Bakker, Neeltje E.M. van Haren, Iris E. Sommer	18
18	Cortical thickness in individuals with non-clinical and clinical psychotic symptoms 2014 ·Brain ·Remko van Lutterveld, Martijn P. van den Heuvel, Kelly Diederen, Antoin D. de Weijer, Marieke Begemann, Rachel M. Brouwer, Kirstin Daalman, Jan Dirk Blom, René S. Kahn, Iris E. Sommer	35
19	Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update 2013 ·Schizophrenia Bulletin ·Iris E. Sommer, Roos van Westrhenen, Marieke Begemann, Lot D. de Witte, Stefan Leucht, René S. Kahn	253
20	Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review 2011 ·Schizophrenia Bulletin ·Iris E. Sommer, Marieke Begemann, (unknown), Stefan Leucht	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact